Pathogen yield and antimicrobial resistance patterns of chronic rhinosinusitis patients presenting to a tertiary rhinology centre

Journal of Otolaryngology - Head and Neck Surgery

Volumn 40, Issue 3, 2011, Pages 232-237

  Genoway, Krista A ^a   Philpott, Carl M ^b,c   Javer, Amin R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c JAMES PAGET UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Antimicrobial resistance; Chronic rhinosinusitis; Methicillin resistant staphylococcus aureus

Indexed keywords

AMOXICILLIN PLUS CLARITHROMYCIN PLUS LANSOPRAZOLE; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CANADA; CHRONIC RHINITIS; CHRONIC SINUSITIS; CYSTIC FIBROSIS; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORAXELLA CATARRHALIS; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RHINOSINUSITIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; CHRONIC DISEASE; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RHINITIS; SINUSITIS; YOUNG ADULT;

EID: 79955443509     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2011.100199     Document Type: Article

References (24)

1. Kingdom TT, Swain RE Jr. The microbiology and antimicrobial resistance patterns in chronic rhinosinusitis. Am J Otolaryngol 2004;25:323-8, doi:10.1016/j.amjoto.2004.03.003. (Pubitemid 39149942)
2. Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps. Rhinol Suppl 2007;20:1-136.
3. Philpott CM, Sharma A, McKiernan DC. Does methicillin-resistant Staphylococcus aureus have a significant role in the peri-operative course of patients undergoing rhinological surgery? J Laryngol Otol 2009;123:191-4, doi:10.1017/S0022215108002855.
4. Sharma A, Philpott C, Pope L, McKiernan D. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery? J Laryngol Otol 2007;121:415-8.
5. Mangram AJ, Horan TC, Pearson ML, et. al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:250-78, doi:10.1086/501620.
6. Nadel DM, Lanza DC, Kennedy DW. Endoscopically guided cultures in chronic sinusitis. Am J Rhinol 1998;12:233-41, doi:10.2500/105065898781390000. (Pubitemid 28402024)
7. Wegner DL. No mercy for MRSA: treatment alternatives to vancomycin and linezolid. MLO Med Lab Obs 2005;37:26-9.
8. Benninger MS, Anon J, Mabry RL. The medical management of rhinosinusitis. Otolaryngol Head Neck Surg 1997;117 (3 Pt 2):S41-9, doi:10.1016/S0194-5998(97) 70006-8.
9. Bhattacharyya N, Kepnes LJ. The risk of development of antimicrobial resistance in individual patients with chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2004;130:1201-4, doi:10.1001/archotol.130.10.1201. (Pubitemid 39371967)
10. Lin A, Busaba NY. Staphylococcus aureus and endoscopic sinus surgery. Curr Opin Otolaryngol Head Neck Surg 2006;14:19-22, doi:10.1097/01.moo. 0000193172.69697.08. (Pubitemid 43269487)
11. Murray PR, editor. Manual of clinical microbiology. 7th ed. Washington (DC): ASM Press; 1999.
12. National Committee for Clinical Laboratory Standards. Methods for Dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A5. Wayne (PA): National Committee for Clinical Laboratory Standards; 2000.
13. National Committee for Clinical Laboratory Standards. Performancy standards for antimicrobial disk susceptibility tests. Approved Standard M2-A7. Wayne (PA): National Committee for Clinical Laboratory Standards; 2000.
14. Hsu J, Lanza DC, Kennedy DW. Antimicrobial resistance in bacterial chronic sinusitis. Am J Rhinol 1998;12:243-8, doi:10.2500/105065898781390055. (Pubitemid 128750966)
15. Manarey CR, Anand VK, Huang C. Incidence of methicillin-resistant Staphylococcus aureus causing chronic rhinosinusitis. Laryngoscope 2004;114:939-41, doi:10.1097/00005537-200405000-00029. (Pubitemid 38625553)
16. Biel MA, Brown CA, Levinson RM, et al. Evaluation of the microbiology of chronic maxillary sinusitis. Ann Otol Rhinol Laryngol 1998;107:942-5.
17. Doyle PW, Woodham JD. Evaluation of the microbiology of chronic ethmoid sinusitis. J Clin Microbiol 1991;29:2396-400.
18. Bolger WE. Gram negative sinusitis: an emerging clinical entity. Am J Rhinol 1994;8:279-84, doi:10.2500/105065894781874205.
19. Brook I. The role of bacteria in chronic rhinosinusitis. Otolaryngol Clin North Am 2005;38:1171-92, doi:10.1016/j.otc.2005.08.007. (Pubitemid 41737830)
20. Brook I, Foote PA, Hausfeld JN. Increase in the frequency of recovery of methicillin-resistant Staphylococcus aureus in acute and chronic maxillary sinusitis. J Med Microbiol 2008;57:1015-7, doi:10.1099/jmm.0.2008/000851-0.
21. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005;40:562-73, doi:10.1086/427701. (Pubitemid 40270226)
22. Thornsberry C, Sahm DF. Resistance of respiratory tract pathogens: an international study 1997-1998. J Chem 2000;12 Suppl 4:16-27.
23. Fung CP, Powell M, Seymour A, et al. The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991. J Antimicrob Chemother 1992;30:47-55, doi:10.1093/jac/30.1.47.
24. Gur D, Ozalp M, Sumerkan B, et al. The prevalence of antimicrobial resistance in Haemophilus influenzae, Streptococcus pneumoniae, Moxaella catarrhalis and Streptococcus pyogenes: results of a multicentre study in Turkey. Int J Antimicron Agents 2002;19:207-11, doi:10.1016/S0924-8579(02)00003- 1. (Pubitemid 34249802)